Your browser doesn't support javascript.
loading
Biallelic NAA60 variants with impaired n-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications.
Chelban, Viorica; Aksnes, Henriette; Maroofian, Reza; LaMonica, Lauren C; Seabra, Luis; Siggervåg, Anette; Devic, Perrine; Shamseldin, Hanan E; Vandrovcova, Jana; Murphy, David; Richard, Anne-Claire; Quenez, Olivier; Bonnevalle, Antoine; Zanetti, M Natalia; Kaiyrzhanov, Rauan; Salpietro, Vincenzo; Efthymiou, Stephanie; Schottlaender, Lucia V; Morsy, Heba; Scardamaglia, Annarita; Tariq, Ambreen; Pagnamenta, Alistair T; Pennavaria, Ajia; Krogstad, Liv S; Bekkelund, Åse K; Caiella, Alessia; Glomnes, Nina; Brønstad, Kirsten M; Tury, Sandrine; Moreno De Luca, Andrés; Boland-Auge, Anne; Olaso, Robert; Deleuze, Jean-François; Anheim, Mathieu; Cretin, Benjamin; Vona, Barbara; Alajlan, Fahad; Abdulwahab, Firdous; Battini, Jean-Luc; Ipek, Rojan; Bauer, Peter; Zifarelli, Giovanni; Gungor, Serdal; Kurul, Semra Hiz; Lochmuller, Hanns; Da'as, Sahar I; Fakhro, Khalid A; Gómez-Pascual, Alicia; Botía, Juan A; Wood, Nicholas W.
Afiliação
  • Chelban V; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK. v.chelban@ucl.ac.uk.
  • Aksnes H; Neurobiology and Medical Genetics Laboratory, "Nicolae Testemitanu" State University of Medicine and Pharmacy, 165, Stefan cel Mare si Sfant Boulevard, MD, 2004, Chisinau, Republic of Moldova. v.chelban@ucl.ac.uk.
  • Maroofian R; Department of Biomedicine, University of Bergen, Bergen, Norway. henriette.aksnes@uib.no.
  • LaMonica LC; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Seabra L; Department of Cell Biology, Yale School of Medicine, New Haven, CT, USA.
  • Siggervåg A; Université Paris Cité, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, INSERM UMR 1163, Paris, France.
  • Devic P; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Shamseldin HE; Hospices Civils de Lyon, Groupement Hospitalier Sud, Service d'Explorations Fonctionnelles Neurologiques, Lyon, France.
  • Vandrovcova J; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Murphy D; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Richard AC; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Quenez O; Univ Rouen Normandie, Inserm U1245, CHU Rouen, Department of Genetics and CNRMAJ, F-76000, Rouen, France.
  • Bonnevalle A; Univ Rouen Normandie, Inserm U1245, CHU Rouen, Department of Genetics and CNRMAJ, F-76000, Rouen, France.
  • Zanetti MN; Univ Rouen Normandie, Inserm U1245, CHU Rouen, Department of Genetics and CNRMAJ, F-76000, Rouen, France.
  • Kaiyrzhanov R; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Salpietro V; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Efthymiou S; South Kazakhstan Medical Academy Shymkent, Shymkent, 160019, Kazakhstan.
  • Schottlaender LV; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Morsy H; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Scardamaglia A; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Tariq A; Instituto de Investigaciones en Medicina Traslacional (IIMT), CONICET-Universidad Austral, Av. Juan Domingo Perón 1500, B1629AHJ, Pilar, Argentina.
  • Pagnamenta AT; Instituto de medicina genómica (IMeG), Hospital Universitario Austral, Universidad Austral, Av. Juan Domingo Perón 1500, B1629AHJ, Pilar, Argentina.
  • Pennavaria A; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Krogstad LS; Department of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
  • Bekkelund ÅK; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Caiella A; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Glomnes N; Oxford NIHR Biomedical Research Centre, Wellcome Centre for Human Genetics, Oxford, United Kingdom.
  • Brønstad KM; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Tury S; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Moreno De Luca A; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Boland-Auge A; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Olaso R; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Deleuze JF; Department of Clinical Science, University of Bergen, 5020, Bergen, Norway.
  • Anheim M; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Cretin B; Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
  • Vona B; Department of Radiology, Autism & Developmental Medicine Institute, Geisinger, Lewisburg, PA, USA.
  • Alajlan F; Department of Radiology, Neuroradiology Section, Kingston Health Sciences Centre, Queen's University Faculty of Health Sciences, Kingston, Ontario, Canada.
  • Abdulwahab F; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France.
  • Battini JL; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France.
  • Ipek R; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France.
  • Bauer P; Neurology Department, Strasbourg University Hospital, Strasbourg, France.
  • Zifarelli G; Strasbourg Federation of Translational Medicine (FMTS), Strasbourg University, Strasbourg, France.
  • Gungor S; INSERM-U964; CNRS-UMR7104, University of Strasbourg, Illkirch-Graffenstaden, France.
  • Kurul SH; Neurology Department, Strasbourg University Hospital, Strasbourg, France.
  • Lochmuller H; Strasbourg Federation of Translational Medicine (FMTS), Strasbourg University, Strasbourg, France.
  • Da'as SI; INSERM-U964; CNRS-UMR7104, University of Strasbourg, Illkirch-Graffenstaden, France.
  • Fakhro KA; Institute of Human Genetics, University Medical Center Göttingen, 37073, Göttingen, Germany.
  • Gómez-Pascual A; Institute for Auditory Neuroscience and InnerEarLab, University Medical Center Göttingen, 37075, Göttingen, Germany.
  • Botía JA; Department of Neuroscience Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Wood NW; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Nat Commun ; 15(1): 2269, 2024 Mar 13.
Article em En | MEDLINE | ID: mdl-38480682
ABSTRACT
Primary familial brain calcification (PFBC) is characterized by calcium deposition in the brain, causing progressive movement disorders, psychiatric symptoms, and cognitive decline. PFBC is a heterogeneous disorder currently linked to variants in six different genes, but most patients remain genetically undiagnosed. Here, we identify biallelic NAA60 variants in ten individuals from seven families with autosomal recessive PFBC. The NAA60 variants lead to loss-of-function with lack of protein N-terminal (Nt)-acetylation activity. We show that the phosphate importer SLC20A2 is a substrate of NAA60 in vitro. In cells, loss of NAA60 caused reduced surface levels of SLC20A2 and a reduction in extracellular phosphate uptake. This study establishes NAA60 as a causal gene for PFBC, provides a possible biochemical explanation of its disease-causing mechanisms and underscores NAA60-mediated Nt-acetylation of transmembrane proteins as a fundamental process for healthy neurobiological functioning.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatias Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatias Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido